Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Bone marrow grafts. Introduction].

P Stryckmans1

  • 1Unité d'hématologie, Institut Jules Bordet, Bruxelles.

Revue Medicale De Bruxelles
|May 1, 1992
PubMed
Summary
This summary is machine-generated.

Allogeneic bone marrow transplantation (BMT) offers potent antileukemic effects and treats genetic disorders. Autologous BMT (ABMT) is effective for hemopathies but has limitations compared to allogeneic BMT.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Measurement of Soluble Interleukin 2 Receptor in Sera of Adult Patients with Hematological or Solid Malignancies.

Leukemia & lymphoma·2016
Same author

Interactions Between Antibody-Coated Iron Micro-Particles and Leukemic Cells as seen by Electron Microscopy.

Leukemia & lymphoma·2016
Same author

Pentostatin (Nipent) in T-cell malignancies. Leukemia Cooperative Group and the European Organization for Research and Treatment of Cancer.

Seminars in oncology·2000
Same author

Pentostatin in T-cell malignancies--a phase II trial of the EORTC. Leukemia Cooperative Group.

Annals of oncology : official journal of the European Society for Medical Oncology·2000
Same author

TGF-beta activity and expression of its receptors in B-cell chronic lymphocytic leukemia.

Leukemia & lymphoma·1998
Same author

Increased incidence of lymphomas and carcinomas in patients with coeliac disease.

European journal of cancer (Oxford, England : 1990)·1998

Area of Science:

  • Hematology
  • Oncology
  • Transplantation Medicine

Context:

  • Bone marrow transplantation (BMT) is a critical therapeutic modality.
  • Allogeneic BMT demonstrates significant antileukemic activity beyond radiochemotherapy.
  • Indications for BMT have expanded to include leukemia, malignant hemopathies, and genetic disorders.

Purpose:

  • To review the efficacy and applications of allogeneic and autologous bone marrow transplantation.
  • To compare the therapeutic benefits and toxicities of different BMT approaches.
  • To highlight the evolving role of BMT in hematologic malignancies and genetic diseases.

Summary:

  • Allogeneic BMT provides powerful antileukemic effects and cures previously untreatable conditions, including genetic disorders of hematopoietic stem cells.

Related Experiment Videos

  • Autologous BMT (ABMT) is effective for malignant hemopathies, primarily enhancing radiochemotherapy effects.
  • While ABMT's efficacy may be lower than allogeneic BMT, its reduced toxicity offers a survival advantage; direct comparison with conventional chemotherapy is ongoing.

    • Impact:

    • Allogeneic BMT expands treatment options for refractory hematologic cancers and genetic disorders.
    • BMT strategies are crucial for improving cure rates and survival in specific patient populations.
    • Careful consideration of patient-specific factors is essential for optimizing BMT outcomes and survival duration.